Powder: -20°C for 3 years
In solvent: -80°C for 2 years
CCT365623 hydrochloride is an orally active inhibitor of lysyl oxidase (LOX) (IC50: 0.89 μM). It suppresses <a href="/target/EGFR" style="display: inline; color: #c13a36">EGFR</a> (pY1068) and <a href="/target/Akt" style="display: inline; color: #c13a36">Akt</a> phosphorylation driven by EGF.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 10-12 weeks | $ 1,170.00 | |
50 mg | 10-12 weeks | $ 2,380.00 | |
100 mg | 10-12 weeks | $ 3,100.00 |
Description | CCT365623 hydrochloride is an orally active inhibitor of lysyl oxidase (LOX) (IC50: 0.89 μM). It suppresses EGFR (pY1068) and AKT phosphorylation driven by EGF. |
Targets&IC50 | LOX:0.89 μM |
In vitro | CCT365623 inhibits LOX at ~5 μM in the biosensor system. CCT365623 (0-40 μM) concentration-dependently decreases the protein levels of surface EGFR. CCT365623 disrupts HTRA1 multimerization, activates TGFβ1 signaling, suppresses MATN2 expression, suppresses EGFR surface retention, and suppresses EGFR signaling. CCT365623 (5 μM) decreases the protein levels of pY1068 EGFR, pAKT, and MATN2, and increases the protein levels of pSMAD2. |
In vivo | CCT365623 (70 mg/kg, oral gavage per day) significantly delays the development of the primary tumors and also suppresses metastatic lung burden in the animals. CCT365623 disrupts EGFR cell surface retention and delays the growth of primary and metastatic tumor cells. CCT365623 exhibits a T1/2PO of 0.6 h and F% (oral bioavailability) of 45%. |
Molecular Weight | 443.99 |
Formula | C18H18ClNO4S3 |
CAS No. | 2126136-98-7 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCT365623 hydrochloride 2126136-98-7 Metabolism Lipoxygenase CCT-365623 hydrochloride Inhibitor inhibitor inhibit